Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Correction to: Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Three weeks of SSRI administration enhances the visual perceptual threshold - a randomized placebo-controlled study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Tryptophan depletion affects compulsive behaviour in rats: strain dependent effects and associated neuromechanisms

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The effect of erythropoietin on electroconvulsive stimulation induced cognitive impairment in rats

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bone mineral density is preserved in men with idiopathic infertility

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Associations of Fish Oil Supplement Use With Testicular Function in Young Men

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

RATIONALE: The novel antipsychotic aripiprazole in use for treatment of schizophrenia is a partial agonist at dopamine D2 receptors with actions at a variety of other receptors as well. Cocaine is believed to exert an important part of its rewarding effect by increasing extracellular levels of dopamine that subsequently act at dopamine D2 receptors.

OBJECTIVES: As a partial agonist, aripiprazole may antagonize effects at D2 receptors and we accordingly tested whether aripiprazole could antagonize self-administration of cocaine. Because D2-like receptor agonists are self-administered, a D2 receptor partial agonist like aripiprazole might itself be reinforcing. Thus, we also assessed whether mice would acquire self-administration of aripiprazole.

MATERIALS AND METHODS: A single session, mouse self-administration procedure was used.

RESULTS: Oral pretreatment with aripiprazole dose-dependently decreased cocaine self-administration under a fixed ratio 1 schedule at the peak cocaine dose (0.03 mg/kg/infusion), reaching significance at 0.2 and 0.4 mg/kg of aripiprazole. Using 0.4 mg/kg, aripiprazole decreased rates of cocaine self-administration without shifting the peak of the dose-response function. There was no effect of aripiprazole per se, suggesting that its inhibitory action was due to effects on cocaine self-administration rather than non-specific motor effects. Aripiprazole was not found to be self-administered in the tested dose range (0.0003-0.3 mg/kg/infusion). The three highest doses (0.03, 0.1, and 0.3 mg/kg/infusion) even caused significant decreases in nose-poking activity, possibly due to extrapyramidal side effects.

CONCLUSIONS: These data are consistent with a potential role for aripiprazole in treatment of cocaine addiction without abuse potential per se.

Original languageEnglish
JournalPsychopharmacology
Volume199
Issue number1
Pages (from-to)37-46
Number of pages10
ISSN0033-3158
DOIs
Publication statusPublished - Jul 2008

    Research areas

  • Animals, Antipsychotic Agents, Brain, Central Nervous System Stimulants, Cocaine, Cocaine-Related Disorders, Dose-Response Relationship, Drug, Male, Methylphenidate, Mice, Mice, Inbred Strains, Motivation, Motor Activity, Motor Skills, Piperazines, Quinolones, Radioligand Assay, Receptors, Dopamine D2, Self Administration

ID: 44737644